JP2001513629A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001513629A5 JP2001513629A5 JP1998536415A JP53641598A JP2001513629A5 JP 2001513629 A5 JP2001513629 A5 JP 2001513629A5 JP 1998536415 A JP1998536415 A JP 1998536415A JP 53641598 A JP53641598 A JP 53641598A JP 2001513629 A5 JP2001513629 A5 JP 2001513629A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9703592.7A GB9703592D0 (en) | 1997-02-21 | 1997-02-21 | Poxvirus chemokine-binding protein |
| GB9703592.7 | 1997-02-21 | ||
| GB9800113.4 | 1998-01-05 | ||
| GBGB9800113.4A GB9800113D0 (en) | 1998-01-05 | 1998-01-05 | A soluble vaccinia virus protein that binds chemokines |
| PCT/GB1998/000569 WO1998037217A1 (en) | 1997-02-21 | 1998-02-23 | A soluble vaccinia virus protein that binds chemokines |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2001513629A JP2001513629A (ja) | 2001-09-04 |
| JP2001513629A5 true JP2001513629A5 (OSRAM) | 2004-12-09 |
| JP4191255B2 JP4191255B2 (ja) | 2008-12-03 |
Family
ID=26311039
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP53641598A Expired - Fee Related JP4191255B2 (ja) | 1997-02-21 | 1998-02-23 | ケモカイン類に結合する可溶性ワクシニアウイルスタンパク質 |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US6355252B1 (OSRAM) |
| EP (2) | EP0985046B1 (OSRAM) |
| JP (1) | JP4191255B2 (OSRAM) |
| AT (1) | ATE323170T1 (OSRAM) |
| AU (1) | AU749921B2 (OSRAM) |
| DE (1) | DE69834179T2 (OSRAM) |
| WO (1) | WO1998037217A1 (OSRAM) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0985046B1 (en) * | 1997-02-21 | 2006-04-12 | Oxxon Therapeutics Limited | Recombinant poxvirus incapable of expressing a41l gene, coding for a soluble protein that binds chemokines |
| GB9711957D0 (en) * | 1997-06-09 | 1997-08-06 | Isis Innovation | Methods and reagents for vaccination |
| WO2002080948A1 (en) * | 2001-04-05 | 2002-10-17 | The Trustees Of Princeton University | Compositions and methods for treating inflammation and related conditions |
| WO2003005953A2 (en) * | 2001-07-12 | 2003-01-23 | Immunex Corporation | Viral proteins capable of binding lar |
| GB0118532D0 (en) * | 2001-07-30 | 2001-09-19 | Isis Innovation | Materials and methods relating to improved vaccination strategies |
| MXPA04002575A (es) * | 2001-09-20 | 2004-06-18 | Schering Corp | Quimiocinas como adyuventes de respuesta inmune. |
| WO2004005892A2 (en) * | 2002-07-10 | 2004-01-15 | The Regents Of The University Of California | Antimicrobial activity of interferon-inducible elr chemokines |
| EP2269619A1 (en) * | 2002-08-12 | 2011-01-05 | Jennerex Biotherapeutics ULC | Methods and compositions concerning poxviruses and cancer |
| US20100189747A1 (en) * | 2003-07-31 | 2010-07-29 | Raymond Weinstein | Compositions and methods for treating or preventing hiv infection |
| US20050175627A1 (en) * | 2003-09-24 | 2005-08-11 | Oxxon Therapeutics Ltd. | HIV pharmaccines |
| WO2006076383A2 (en) * | 2005-01-11 | 2006-07-20 | Rosetta Stone Labs, Llc | Composition and method for inducing a protective vaccine response |
| US20070160571A1 (en) * | 2006-01-11 | 2007-07-12 | Mitchell Krathwohl | Composition and method for inducing protective vaccine response |
| CN101351213B (zh) * | 2005-09-07 | 2013-10-02 | 詹纳里克斯公司 | 使用表达gm-csf的痘病毒系统性治疗转移性癌和/或全身散布性癌 |
| US8980246B2 (en) | 2005-09-07 | 2015-03-17 | Sillajen Biotherapeutics, Inc. | Oncolytic vaccinia virus cancer therapy |
| AU2006297173A1 (en) * | 2005-09-29 | 2007-04-12 | Viral Logic Systems Technology Corp. | Immunomodulatory compositions and uses therefor |
| EP2005185B1 (en) | 2006-03-22 | 2010-10-20 | Viral Logic Systems Technology Corp. | Methods for identifying polypeptide targets |
| US20110044945A1 (en) * | 2007-02-08 | 2011-02-24 | Rappaport Family Institute For Research In The Medical Sciences | Agents for the treatment of multiple sclerosis and methods of using same |
| KR20080084528A (ko) * | 2007-03-15 | 2008-09-19 | 제네렉스 바이오테라퓨틱스 인크. | 종양살상형 백시니아 바이러스 암 치료 |
| EP2164508B1 (en) | 2007-06-04 | 2014-01-08 | Rappaport Family Institute for Research in the Medical Sciences | Agents for the treatment of inflammatory diseases and methods of using same |
| WO2009082594A2 (en) * | 2007-11-26 | 2009-07-02 | Fox Chase Cancer Center | Secreted/cell bound poxvirus proteins and methods of use thereof as vaccines and anti-viral agents |
| WO2010103517A1 (en) | 2009-03-12 | 2010-09-16 | Rappaport Family Institute For Research In The Medical Sciences | Soluble compositions for the treatment of cxcr3-ligand associated diseases |
| ES2671570T3 (es) | 2009-09-14 | 2018-06-07 | Sillajen Biotherapeutics, Inc. | Terapia combinada contra el cáncer con virus oncolítico de vaccinia |
| CN103429258B (zh) | 2011-01-04 | 2016-03-09 | 新罗杰公司 | 通过施用溶瘤痘苗病毒生成针对肿瘤抗原的抗体和生成肿瘤特异性补体依赖性细胞毒性 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5834419A (en) | 1995-04-19 | 1998-11-10 | The John P. Robarts Institute | Chemokine binding protein and methods of use therefor |
| US6140064A (en) | 1996-09-10 | 2000-10-31 | Theodor-Kocher Institute | Method of detecting or identifying ligands, inhibitors or promoters of CXC chemokine receptor 3 |
| WO1998036766A1 (en) * | 1997-02-21 | 1998-08-27 | Isis Innovation Limited | Anti-hiv protein |
| EP0985046B1 (en) * | 1997-02-21 | 2006-04-12 | Oxxon Therapeutics Limited | Recombinant poxvirus incapable of expressing a41l gene, coding for a soluble protein that binds chemokines |
| JP2001168323A (ja) * | 1999-12-06 | 2001-06-22 | Mitsubishi Electric Corp | 半導体装置の製造方法 |
-
1998
- 1998-02-23 EP EP98907032A patent/EP0985046B1/en not_active Expired - Lifetime
- 1998-02-23 DE DE69834179T patent/DE69834179T2/de not_active Expired - Fee Related
- 1998-02-23 US US09/367,781 patent/US6355252B1/en not_active Expired - Fee Related
- 1998-02-23 AT AT98907032T patent/ATE323170T1/de not_active IP Right Cessation
- 1998-02-23 WO PCT/GB1998/000569 patent/WO1998037217A1/en not_active Ceased
- 1998-02-23 AU AU63020/98A patent/AU749921B2/en not_active Ceased
- 1998-02-23 EP EP20030022117 patent/EP1405916A1/en not_active Withdrawn
- 1998-02-23 JP JP53641598A patent/JP4191255B2/ja not_active Expired - Fee Related
-
2002
- 2002-01-15 US US10/047,761 patent/US20020071849A1/en not_active Abandoned
-
2004
- 2004-02-18 US US10/781,262 patent/US7384643B2/en not_active Expired - Fee Related